Spine Surgery Market Survey

A Survey of 50 Orthopedic Surgeons and Neurosurgeons

 

Price: $2500

Deliverables: Survey Data Only

 

Please contact Howard.Brick@panelintelligence.com to purchase.

 

Screening Questions

S1.      What is your primary medical specialty?

  Orthopedic Surgery

  Neurosurgery

  Other, non-spine surgery, specify __________ [Terminate]

 

S2.      Are you board certified in your specialty?

  Yes

  No [Terminate]

<Page Break>     

S3.      Approximately how many years have you been in practice post-training?

            _____ years (TERMINATE <2 OR >30)

 

S4.      How many spinal fusions (of all types) do you perform per year?

________ spinal fusions (TERMINATE if less than 50)

<Page Break>     

S5.      Which of the following best describes the most common place you perform your spinal fusion cases?

  Academic Hospital

  Community Hospital

  Hospital-Owned ASC

  Physician-Owned ASC

  ASC Owned Jointly by Hospital and Physicians

 

 (Standard Qualify Text)

<Page Break>     


 

 

1.         Do you practice in an academic or community setting?

  Academic setting

  Community setting

 

 

 

2.         What payer mix are you seeing in your practice for spinal fusions?

Medicare:____

Medicaid:_____

Workers Comp:_______

Private Insurers: ________

Self-Insured:  ________

Other: ________

Force sum = 100%

<Page Break>     

3.         What is your average surgical backlog/wait time for spinal procedures (in weeks)?

            _____ weeks: Currently

            _____ weeks: Three Months Ago

[Allow Decimals]

<Page Break>     

 

4.         How many lumbar spinal fusion procedures do you perform a year?

            _____ lumbar spinal fusions per year

 

 

5.         In 3Q09 (July 09 – Sept 09), have you noticed growth in your lumbar spinal fusion procedure volume versus last quarter (Mar 09– June 09)?

  My lumbar spinal fusion procedural volume was UNCHANGED this quarter (July 09 – Sept 09) versus last quarter (Mar 09– June 09)

  My lumbar spinal fusion procedural volume this quarter (July 09 – Sept 09) was GREATER THAN last quarter (Mar 09– June 09)

  My lumbar spinal fusion procedural volume this quarter (July 09 – Sept 09) was LESS THAN last quarter (Mar 09– June 09)

<Page Break>     

 

6.         In full year 2010, what do you expect will be the growth in your lumbar spinal fusion procedure volume versus the same time last year?

  I expect 0-3% growth in lumbar spinal fusion procedural volume for full year 2010 versus full year 2009

  I expect 3-6% growth in lumbar spinal fusion procedural volume for full year 2010 versus full year 2009

  I expect 6-9% growth in lumbar spinal fusion procedural volume for full year 2010 versus full year 2009

  I expect 9-12% growth in lumbar spinal fusion procedural volume for full year 2010 versus full year 2009

  I expect greater than 12% growth in lumbar spinal fusion procedural volume for full year 2010 versus full year 2009

<Page Break>     

7.         How many cervical spinal fusion procedures do you perform a year?

 

            _______ cervical spinal fusions per year

 

8.         In 3Q09 (July 09 – Sept 09), have you noticed growth in your cervical spinal fusion procedural volume versus last quarter (Mar 09– June 09)?

  My cervical spinal fusion procedural volume was UNCHANGED this quarter (July 09 – Sept 09) versus last quarter (Mar 09– June 09)

  My cervical spinal fusion procedural volume this quarter (July 09 – Sept 09) was GREATER THAN last quarter (Mar 09– June 09)

  My cervical spinal fusion procedural volume this quarter (July 09 – Sept 09) was LESS THAN last quarter (Mar 09– June 09)

<Page Break>     

9.         In full year 2010, what do you expect will be the growth in your cervical spinal fusion procedure volume versus the same time last year?

  I expect 0-3% growth in cervical spinal fusion volume for full year 2010 versus full year 2009

  I expect 3-6% growth in cervical spinal fusion volume for full year 2010 versus full year 2009

  I expect 6-9% growth in cervical spinal fusion volume for full year 2010 versus full year 2009

  I expect 9-12% growth in cervical spinal fusion volume for full year 2010 versus full year 2009

  I expect greater than 12% growth in cervical spinal fusion volume for full year 2010 versus full year 2009

<Page Break>     

 

10.        What is the largest opportunity for volume growth in your practice?

  Spinal fusions using the lateral lumbar approach

  Kyphoplasty/Vertebroplasty procedures

  Dynamic stabilization procedures

  Older/osteoporosis patients

  Performing disc procedures in the cervical spine

<Page Break>     

 

11.        What percentage of insurance companies in your region (approximately) currently authorize reimbursement for artificial cervical disc procedures?

 

_________% of insurers

<Page Break>     

12.        Which company’s spinal technology has the biggest opportunity to gain market share in your practice in 2010?

  Medtronic has the biggest opportunity to gain market share in my practice in 2010

  Zimmer/Abbott Spine has the biggest opportunity to gain market share in my practice in 2010

  Stryker has the biggest opportunity to gain market share in my practice in 2010

  J&J/Depuy has the biggest opportunity to gain market share in my practice in 2010

  NuVasive has the biggest opportunity to gain market share in my practice in 2010

  Synthes has the biggest opportunity to gain market share in my practice in 2010

  None of them have a chance to increase share in my practice, please explain TEXT BOX

 

 

 

13.        How much incremental market share (as a %) do you think the spinal manufacturer you identified in the previous question will gain in your practice for 2010?

  I think the manufacturer will gain 0-1% market share in my practice for 2010

  I think the manufacturer will gain 1-2% market share in my practice for 2010

  I think the manufacturer will gain 2-3% market share in my practice for 2010

  I think the manufacturer will gain 3-4% market share in my practice for 2010

<Page Break>     

 

14.        Which company’s spinal technology has the largest risk of losing market share in your practice in 2010?

  Medtronic has the largest risk of losing market share in my practice in 2010

  Zimmer/Abbott Spine has the largest risk of losing market share in my practice in 2010

  Stryker has the largest risk of losing market share in my practice in 2010

  J&J/Depuy has the largest risk of losing market share in my practice in 2010

  NuVasive has the largest risk of losing market share in my practice in 2010

  Synthes has the largest risk of losing market share in my practice in 2010

  None of them have a chance to lose share in my practice, please explain TEXT BOX

 

 

 

15.        How much incremental market share (as a %) do you think the spinal fusion manufacturer you identified in the previous question will lose in your practice for 2010?

  I think the manufacturer will lose 0-1% market share in my practice for 2010

  I think the manufacturer will lose 1-2% market share in my practice for 2010

  I think the manufacturer will lose 2-3% market share in my practice for 2010

  I think the manufacturer will lose 3-4% market share in my practice for 2010

 

<Page Break>     

 

16.        JNJ/Depuy, Medtronic, and Synthes combined have greater than 60% market share in the spine market. However, their share has been eroding at the hands of smaller companies. Which small company has the largest opportunity to gain share in your practice in 2010?

  Orthofix

  Nuvasive

  Globus

  Alphatec

  Integra Lifesciences

  Biomet

  None of them have a chance to increase share in my practice, please explain TEXT BOX

 

 

17.        Why does the spinal manufacturer you identified in the previous question have the largest opportunity to gain share in your practice in 2010?

  Better sales force/account management

  Improved product flow/technology

  Better Pricing

<Page Break>     

 

18.        Which smaller competitor has done the best job of increasing sales force presence through hiring more reps or increasing distributors in your practice in 2009?

  Orthofix

  Nuvasive

  Globus

  Alphatec

  Integra Lifesciences

  Biomet

  None of them have done a good job increasing their sales force

<Page Break>     

19.        What percentage of your cases involves patients over the age of 65?

  0-10% of my cases involve patients >65 years old

  11-20% of my cases involve patients >65 years old

  21-30% of my cases involve patients >65 years old

  31-40% of my cases involve patients >65 years old

  Greater than 40% of my cases involve patients >65 years old

 

 

20.        Would you increase your surgical volume of patients over the age of 65 if better technologies existed?

  Yes

  No

 

<Page Break>     

21.        Which bone grafting option has the most opportunity for growth in your practice for 2010?

  Allograft – Ceramic (i.e. Vitoss Morsels, Actifuse, Novabone, Mastergraft Granules, Pro Osteron)

  Allograft - Ceramic w/ collagen (i.e. Healos, Mozaik, Formagraft, Mastergraft Matrix, Vitoss Foam)

  Allograft – Cancellous & Cortical Bone (i.e. Osteocel, Trinity)

  Allograft – Demineralized Bone Matrix – DBM (i.e. Grafton, DBX, Accell, Progenix DBM Putty)

  Bone Morphogentic Protein – rhBMP (i.e. Infuse Bone Graft, OP-1 Putty/Implant)

 

<Page Break>     

22.        Which allograft - Cancellous & Cortical Bone grafting option has the most opportunity for growth in your practice for 2010?

  I do not expect to use these products.

  Trinity Evolution (OrthoFix)

  Osteocel Plus (Nuvasive)

end survey


Print Abstract

For additional information on this study or to purchase, please call:

Survey
Orthopedic Surgery
Panel Intelligence, LLC, 150 Cambridgepark Drive, 7th Floor, Cambridge, MA 02140 617 532 5700